Combined Diosmectite and Mesalazine Treatment for Mild-to-Moderate Ulcerative Colitis: A Randomized, Placebo-Controlled Study

BACKGROUND: The relapse rate of ulcerative colitis (UC) is high. The efficacy of combined diosmectite and mesalazine treatment for active mild-to-moderate UC was investigated. MATERIAL/METHODS: A total of 120 patients with UC were enrolled in this randomized, single-blind, placebo-controlled study....

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xue-Liang, Wang, Hua-Hong, Cui, Hui-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Drug Controlled Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301466/
https://www.ncbi.nlm.nih.gov/pubmed/25582578
http://dx.doi.org/10.12659/MSM.891400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301466/
https://www.ncbi.nlm.nih.gov/pubmed/25582578
http://dx.doi.org/10.12659/MSM.891400

Ejemplares similares